95 related articles for article (PubMed ID: 12223224)
1. Enhancement of osteogenesis in vitro by a novel osteoblast differentiation-promoting compound, TAK-778, partly through the expression of Msx2.
Gotoh M; Notoya K; Ienaga Y; Kawase M; Makino H
Eur J Pharmacol; 2002 Sep; 451(1):19-25. PubMed ID: 12223224
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.
Notoya K; Nagai H; Oda T; Gotoh M; Hoshino T; Muranishi H; Taketomi S; Sohda T; Makino H
J Pharmacol Exp Ther; 1999 Sep; 290(3):1054-64. PubMed ID: 10454478
[TBL] [Abstract][Full Text] [Related]
3. The effect of TAK-778 on gene expression of osteoblastic cells is mediated through estrogen receptor.
Bellesini LS; Beloti MM; Crippa GE; Bombonato-Prado KF; Junta CM; Marques MM; Passos GA; Rosa AL
Exp Biol Med (Maywood); 2009 Feb; 234(2):190-9. PubMed ID: 19064943
[TBL] [Abstract][Full Text] [Related]
4. TAK-778 enhances osteoblast differentiation of human bone marrow cells via an estrogen-receptor-dependent pathway.
Rosa AL; Beloti MM
J Cell Biochem; 2004 Mar; 91(4):749-55. PubMed ID: 14991766
[TBL] [Abstract][Full Text] [Related]
5. TAK-778 enhances osteoblast differentiation of human bone marrow cells.
Rosa AL; Beloti MM
J Cell Biochem; 2003 Aug; 89(6):1148-53. PubMed ID: 12898513
[TBL] [Abstract][Full Text] [Related]
6. Participation of estrogen receptors in the enhancement of osteoblast differentiation by TAK-778.
Beloti MM; Bellesini LS; de Oliveira PT; Rosa AL
Mol Cell Biochem; 2006 Apr; 285(1-2):101-9. PubMed ID: 16477374
[TBL] [Abstract][Full Text] [Related]
7. TAK-778 enhances osteoblast differentiation of human bone marrow cells cultured on titanium.
Rosa AL; Beloti MM
Biomaterials; 2003 Aug; 24(17):2927-32. PubMed ID: 12742732
[TBL] [Abstract][Full Text] [Related]
8. A one-step enzyme-linked immunosorbent assay for a novel osteoblast differentiation-promoting compound, TAK-778 in serum.
Kurokawa T; Hoshino T; Oda T; Saito K; Ogawa Y
Biol Pharm Bull; 1999 Dec; 22(12):1266-70. PubMed ID: 10746152
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release microcapsules of a bone formation stimulant, TAK-778, for local injection into a fracture site.
Hoshino T; Saito K; Muranishi H; Sohda T; Ogawa Y
J Pharm Sci; 2001 Dec; 90(12):2121-30. PubMed ID: 11745771
[TBL] [Abstract][Full Text] [Related]
10. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
Malaval L; Modrowski D; Gupta AK; Aubin JE
J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.
Cheng SL; Yang JW; Rifas L; Zhang SF; Avioli LV
Endocrinology; 1994 Jan; 134(1):277-86. PubMed ID: 8275945
[TBL] [Abstract][Full Text] [Related]
12. TAK-778 induces osteogenesis in ovariectomized rats via an estrogen receptor-dependent pathway.
Cai M; Yu Y; Feng S; Tao K; Li S; Deng L; Cai Z
J Bone Miner Metab; 2011 Mar; 29(2):168-73. PubMed ID: 20700613
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel 2-benzothiopyran and 3-benzothiepin derivatives and their stimulatory effect on bone formation.
Oda T; Notoya K; Gotoh M; Taketomi S; Fujisawa Y; Makino H; Sohda T
J Med Chem; 1999 Feb; 42(4):751-60. PubMed ID: 10052981
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of fracture repair in rats with streptozotocin-induced diabetes by a single injection of biodegradable microcapsules containing a bone formation stimulant, TAK-778.
Hoshino T; Muranishi H; Saito K; Notoya K; Makino H; Nagai H; Sohda T; Ogawa Y
J Biomed Mater Res; 2000 Sep; 51(3):299-306. PubMed ID: 10880070
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation.
Gori F; Thomas T; Hicok KC; Spelsberg TC; Riggs BL
J Bone Miner Res; 1999 Sep; 14(9):1522-35. PubMed ID: 10469280
[TBL] [Abstract][Full Text] [Related]
16. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2.
Rickard DJ; Sullivan TA; Shenker BJ; Leboy PS; Kazhdan I
Dev Biol; 1994 Jan; 161(1):218-28. PubMed ID: 8293874
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures.
Leboy PS; Beresford JN; Devlin C; Owen ME
J Cell Physiol; 1991 Mar; 146(3):370-8. PubMed ID: 2022691
[TBL] [Abstract][Full Text] [Related]
18. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
19. [Effect of beta-TCP containing the bone-growth promoting compound, TAK-778, on the vertex bone of rat--change of volmetric bone formation corresponding to the containing volume of TAK-778].
Sasazawa T; Yoshie N; Watanabe F; Hata Y
Nihon Hotetsu Shika Gakkai Zasshi; 2006 Jul; 50(3):422-31. PubMed ID: 17159288
[TBL] [Abstract][Full Text] [Related]
20. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
